Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Eye Movement Desensitization and Reprocessing Versus Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder and Comorbid Disorders in Pakistan: A Full-Fledged Randomized Controlled Trial

NCT06435052 is registered in ClinicalTrials.gov with Khushal Khan Khattak Univeristy, Karak, Pakistan as lead sponsor.

NCT NCT06435052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Eye Movement Desensitization and Reprocessing Versus Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder and Comorbid Disorders in Pakistan: A Full-Fledged Randomized Controlled Trial
Lead sponsor
Khushal Khan Khattak Univeristy, Karak, Pakistan
Phase
Not applicable
Overall status
Completed
Start date
May 10, 2022
Completion date
March 1, 2024
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, post-traumatic stress disorder